Teligent, Inc. (NASDAQ:TLGT)‘s stock had its “hold” rating reissued by research analysts at Deutsche Bank AG in a report released on Monday. They presently have a $9.00 target price on the stock, up from their prior target price of $8.00. Deutsche Bank AG’s target price suggests a potential upside of 5.14% from the stock’s current price.

Separately, Zacks Investment Research cut shares of Teligent from a “hold” rating to a “sell” rating in a research note on Thursday, July 6th.

Teligent (NASDAQ:TLGT) traded down 0.82% during midday trading on Monday, reaching $8.49. The company’s stock had a trading volume of 56,535 shares. The company’s 50-day moving average is $8.87 and its 200 day moving average is $7.95. Teligent has a 52 week low of $5.74 and a 52 week high of $9.54. The firm’s market capitalization is $451.89 million.

TRADEMARK VIOLATION WARNING: “Deutsche Bank AG Reiterates “Hold” Rating for Teligent, Inc. (TLGT)” was originally reported by Watch List News and is owned by of Watch List News. If you are viewing this piece of content on another publication, it was stolen and republished in violation of United States & international trademark & copyright legislation. The legal version of this piece of content can be read at https://www.watchlistnews.com/deutsche-bank-ag-reiterates-hold-rating-for-teligent-inc-tlgt/1452624.html.

Hedge funds and other institutional investors have recently modified their holdings of the company. Teza Capital Management LLC acquired a new position in shares of Teligent during the first quarter worth $116,000. Round Table Services LLC boosted its position in shares of Teligent by 46.6% in the first quarter. Round Table Services LLC now owns 19,478 shares of the company’s stock worth $152,000 after buying an additional 6,191 shares during the period. UBS Asset Management Americas Inc. acquired a new position in shares of Teligent during the first quarter worth $170,000. Cutler Group LP boosted its position in shares of Teligent by 217.6% in the first quarter. Cutler Group LP now owns 23,923 shares of the company’s stock worth $186,000 after buying an additional 16,391 shares during the period. Finally, Renaissance Technologies LLC acquired a new position in shares of Teligent during the first quarter worth $198,000. 63.57% of the stock is owned by institutional investors and hedge funds.

About Teligent

Teligent, Inc is a specialty generic pharmaceutical company. Under the Company’s own label, it markets and sells generic injectable pharmaceutical products in the United States and Canada. In the United States it marketed 16 generic topical pharmaceutical products and four branded generic pharmaceutical products, as of December 31, 2016.

Receive News & Ratings for Teligent Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teligent Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.